首站-论文投稿智能助手
典型文献
Mass spectrometry imaging:new eyes on natural products for drug research and development
文献摘要:
Natural products(NPs)and their structural analogs represent a major source of novel drug development for disease prevention and treatment.The development of new drugs from NPs includes two crucial aspects.One is the discovery of NPs from medicinal plants/microorganisms,and the other is the evaluation of the NPs in vivo at various physiological and pathological states.The heterogeneous spatial distribution of NPs in medicinal plants/microorganisms or In vivo can provide valuable information for drug development.However,few molecular imaging technologies can detect thousands of compounds simultaneously on a label-free basis.Over the last two decades,mass spectrometry imaging(MSI)methods have progressively improved and diversified,thereby allowing for the development of various applications of NPs in plants/microorganisms and in vivo NP research.Because MSI allows for the spatial mapping of the production and distribution of numerous molecules in situ without labeling,it provides a visualization tool for NP research.Therefore,we have focused this mini-review on summarizing the applications of MSI technology in discovering NPs from medicinal plants and evaluating NPs in preclinical studies from the perspective of new drug research and development(R&D).Additionally,we briefly reviewed the factors that should be carefully considered to obtain the desired MSI results,Finally,the future development of MSI in new drug R&D is proposed.
文献关键词:
作者姓名:
Jin-jun Hou;Zi-jia Zhang;Wen-yong Wu;Qing-qing He;Teng-qian Zhang;Ya-wen Liu;Zhao-jun Wang;Lei Gao;Hua-li Long;Min Lei;Wan-ying Wu;De-an Guo
作者机构:
National Engineering Research Center of TCM Standardization Technology,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;School of Chinese Materia Medica,Nanjing University of Chinese Medicine,Nanjing 210029,China
引用格式:
[1]Jin-jun Hou;Zi-jia Zhang;Wen-yong Wu;Qing-qing He;Teng-qian Zhang;Ya-wen Liu;Zhao-jun Wang;Lei Gao;Hua-li Long;Min Lei;Wan-ying Wu;De-an Guo-.Mass spectrometry imaging:new eyes on natural products for drug research and development)[J].中国药理学报(英文版),2022(12):3096-3111
A类:
B类:
Mass,spectrometry,imaging,new,eyes,natural,products,research,development,Natural,NPs,their,structural,analogs,represent,major,source,novel,disease,prevention,treatment,drugs,from,includes,two,crucial,aspects,One,discovery,medicinal,plants,microorganisms,other,evaluation,vivo,various,physiological,pathological,states,heterogeneous,spatial,distribution,In,can,valuable,information,However,few,molecular,technologies,detect,thousands,compounds,simultaneously,free,basis,Over,last,decades,mass,MSI,methods,have,progressively,improved,diversified,thereby,allowing,applications,Because,allows,mapping,production,numerous,molecules,situ,without,labeling,provides,visualization,tool,Therefore,focused,this,mini,summarizing,technology,discovering,evaluating,preclinical,studies,perspective,Additionally,briefly,reviewed,factors,that,should,carefully,considered,obtain,desired,results,Finally,future,proposed
AB值:
0.552486
相似文献
High-throughput"read-on-ski"automated imaging and label-free detection system for toxicity screening of compounds usingpersonalised human kidney organoids
Qizheng WANG;Jun LU;Ke FAN;Yiwei XU;Yucui XIONG;Zhiyong SUN;Man ZHAI;Zhizhong ZHANG;Sheng ZHANG;Yan SONG;Jianzhong LUO;Mingliang YOU;Meijin GUO;Xiao ZHANG-State Key Laboratory of Bioreactor Engineering,East China University of Science and Technology,Shanghai 200237,China;Guangzhou Institutes of Biomedicine and Health,Chinese Academy of Sciences,Guangzhou 510530,China;Bioland Laboratory(Guangzhou Regenerative Medicine and Health Guangdong Laboratory),Guangzhou 510320,China;Hangzhou Cancer Institute,Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province,Affiliated Hangzhou Cancer Hospital,Zhejiang University School of Medicine,Hangzhou 310002,China
The mini player with diverse functions:extracellular vesicles in cell biology,disease,and therapeutics
Abhimanyu Thakur;Xiaoshan Ke;Ya-Wen Chen;Pedram Motalllebnejad;Kui Zhang;Qizhou Lian;Huanhuan Joyce Chen-The Pritzker School of Molecular Engineering,The University of Chicago,Chicago,Illinois,USA;The Ben May Department for Cancer Research,The University of Chicago,Chicago,Illinois,USA;Division of Pulmonary,Critical Care and Sleep Medicine,Department of Medicine,Keck School of Medicine,Hastings Center for Pulmonary Research,University of Southern California,Los Angeles,CA 90089,USA;Department of Stem Cell Biology and Regenerative Biology,Keck School of Medicine,University of Southern California,Los Angeles,CA 90089,USA;Department of Medicine,Li Ka Shing Faculty of Medicine,The University of Hong Kong,Pok Fu Lam,Hong Kong;Prenatal Diagnostic Center and Cord Blood Bank,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou,China;HKUMed Laboratory of Cellular Therapeutics,the University of Hong Kong,Pok Fu Lam,Hong Kong
Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD:A promising drug Potentilla discolor Bunge
Longshan Ji;Qian Li;Yong He;Xin Zhang;Zhenhua Zhou;Yating Gao;Miao Fang;Zhuo Yu;Robim M.Rodrigues;Yueqiu Gao;Man Li-Laboratory of Cellular Immunity,Institute of Clinical Immunology,Shanghai Key Laboratory of Traditional Chinese Medicine,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Key Laboratory of Liver and Kidney Diseases(Shanghai University of Traditional Chinese Medicine),Ministry of Education,Shanghai 201203,China;Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;Department of Hepatopathy,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Department of in Vitro Toxicology and Dermato-Cosmetology,Faculty of Medicine and Pharmacy,Vrije Universiteit Brussel,Brussels 1000,Belgium
Evolution of drug regulations and regulatory innovation for anticancer drugs in China
Yang Liu;Ning Zhang;Cuicui Xie;Yale Jiang;Yunhe Qin;Liyun Zhou;Yi Fan;Lianjie Ren;Chen Yin;Huan Yang;Wei Xie;Qing Zhai;Guanqiao Li;Hongzhuan Chen;Xiaoyuan Chen-Tsinghua Clinical Research Institute(TCRI),School of Medicine,Tsinghua University,Beijing 100084,China;Center for Drug Evaluation,National Medical Products Administration,Beijing 100038,China;Pharmcube(Beijing)Co.,Ltd.,Beijing 100102,China;Department of Clinical Pharmacy,Cancer Hospital of Fudan University,Shanghai 200032,China;Vanke School of Public Health,Tsinghua University,Beijing 100084,China;Shanghai Collaborative Innovation Center for Translational Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Office of Clinical Trial Institute,Beijing Tsinghua Changgung Hospital,Beijing 102218,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。